News and Media

Quantum Genomics strengthens its management team by appointing Marc Karako, Chief Financial Officer, and Jean-Philippe Milon, Chief Operating Officer – 2014-05-14

15 May 2014
|

Quantum Genomics, an innovative biopharmaceutical company developing new therapies for cardiovascular diseases (Alternext – FR0011648971 – ALQGC), announces the appointment of Marc Karako and Jean-Philippe Milon, respectively CFO and COO. They will strengthen the management team of Quantum Genomics, supporting Lionel Ségard, Chairman and […]

Additional private placement of 240K€ : total fundraising increased to 3 650 K€ in 2014

30 April 2014
|

Quantum Genomics, a biopharmaceutical research company developing new treatments in the field of cardiovascular diseases, (Alternext – FR0011648971 – ALQGC), has announced today a capital increase by additional private placements of 240 K€ at the same price per share as the private placement of 3.4 M€ made on April […]

Free Market – Alternext: Quantum Genomics passes a new milestone

14 April 2014
|

Listed on the open market since the summer of 2009, Quantum Genomics has just transferred its shares on Alternext this week […]

Quantum Genomics transfers its shares to Alternext Paris as of April 10, 2014, following a capital increase of €3.4 million

9 April 2014
|

Quantum Genomics, a biopharmaceutical research company developing new treatments in the field of cardiovascular diseases, has announced a capital increase gained through private placements totalling €3.4 million through the issuance of 637,334 new shares at a unit price of €5.35.
Following this transaction, Quantum Genomics […]